An experimental drug can improve sociability in patients with fragile X syndrome and may be helpful as a treatment for autism, according to the authors of a new study. Christopher McDougle, Nancy Lurie Marks Professor of Psychiatry at Massachusetts General Hospital, is quoted.
News & Research
